112 related articles for article (PubMed ID: 17998676)
1. Enhancement of radionuclide induced cytotoxicity by 2-deoxy-D-glucose in human tumor cell lines.
Shrivastava V; Mishra AK; Dwarakanath BS; Ravindranath T
J Cancer Res Ther; 2006; 2(2):57-64. PubMed ID: 17998676
[TBL] [Abstract][Full Text] [Related]
2. 2-deoxy-D-glucose enhances the cytotoxicity of topoisomerase inhibitors in human tumor cell lines.
Dwarakanath BS; Khaitan D; Ravindranath T
Cancer Biol Ther; 2004 Sep; 3(9):864-70. PubMed ID: 15254410
[TBL] [Abstract][Full Text] [Related]
3. Hematoporphyrin derivatives potentiate the radiosensitizing effects of 2-deoxy-D-glucose in cancer cells.
Dwarakanath BS; Adhikari JS; Jain V
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1125-33. PubMed ID: 10192364
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines.
Dwarkanath BS; Zolzer F; Chandana S; Bauch T; Adhikari JS; Muller WU; Streffer C; Jain V
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):1051-61. PubMed ID: 11429233
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitization by 6-aminonicotinamide and 2-deoxy-D-glucose in human cancer cells.
Varshney R; Dwarakanath B; Jain V
Int J Radiat Biol; 2005 May; 81(5):397-408. PubMed ID: 16076755
[TBL] [Abstract][Full Text] [Related]
6. The glycolytic inhibitor 2-deoxy-D-glucose enhances the efficacy of etoposide in ehrlich ascites tumor-bearing mice.
Gupta S; Mathur R; Dwarakanath BS
Cancer Biol Ther; 2005 Jan; 4(1):87-94. PubMed ID: 15711125
[TBL] [Abstract][Full Text] [Related]
7. Differential cytotoxicity of the glycolytic inhibitor 2-deoxy-D-glucose in isogenic cell lines varying in their p53 status.
Vibhuti A; Muralidhar K; Dwarakanath BS
J Cancer Res Ther; 2013; 9(4):686-92. PubMed ID: 24518718
[TBL] [Abstract][Full Text] [Related]
8. Glycolytic inhibitor, 2-deoxy-D-glucose, does not enhance radiation-induced apoptosis in mouse thymocytes and splenocytes in vitro.
Swamy RK; Manickam J; Adhikari JS; Dwarakanath BS
Indian J Exp Biol; 2005 Aug; 43(8):686-92. PubMed ID: 16121709
[TBL] [Abstract][Full Text] [Related]
9. Short-term exposure of multicellular tumor spheroids of a human glioma cell line to the glycolytic inhibitor 2-deoxy-D-glucose is more toxic than continuous exposure.
Khaitan D; Chandna S; Dwarakanath SB
J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S67-73. PubMed ID: 20009299
[TBL] [Abstract][Full Text] [Related]
10. 2-Deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion.
Xi H; Kurtoglu M; Liu H; Wangpaichitr M; You M; Liu X; Savaraj N; Lampidis TJ
Cancer Chemother Pharmacol; 2011 Apr; 67(4):899-910. PubMed ID: 20593179
[TBL] [Abstract][Full Text] [Related]
11. Modulation of cellular radiation responses by 2-deoxy-D-glucose and other glycolytic inhibitors: implications for cancer therapy.
Kalia VK; Prabhakara S; Narayanan V
J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S57-60. PubMed ID: 20009297
[TBL] [Abstract][Full Text] [Related]
12. Differential mechanisms of radiosensitization by 2-deoxy-D-glucose in the monolayers and multicellular spheroids of a human glioma cell line.
Khaitan D; Chandna S; Arya MB; Dwarakanath BS
Cancer Biol Ther; 2006 Sep; 5(9):1142-51. PubMed ID: 16855378
[TBL] [Abstract][Full Text] [Related]
13. Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.
Aft RL; Lewis JS; Zhang F; Kim J; Welch MJ
Cancer Res; 2003 Sep; 63(17):5496-504. PubMed ID: 14500386
[TBL] [Abstract][Full Text] [Related]
14. Altered gene expression induced by ionizing radiation and glycolytic inhibitor 2-deoxy-glucose in a human glioma cell line: implications for radio sensitization.
Heminger K; Jain V; Kadakia M; Dwarakanath B; Berberich SJ
Cancer Biol Ther; 2006 Jul; 5(7):815-23. PubMed ID: 16760658
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of radiation effects in plateau phase human glioma cells by combination of metabolic inhibitors.
Kalia VK
Indian J Exp Biol; 1993 Apr; 31(4):312-5. PubMed ID: 8359829
[TBL] [Abstract][Full Text] [Related]
16. Differential modification of radiation damage in 5-bromo-2-deoxy-uridine sensitized human glioma cells and PHA-stimulated peripheral leukocytes by 2-deoxy-D-glucose.
Kalia VK; Devi NK
Indian J Exp Biol; 1994 Sep; 32(9):637-42. PubMed ID: 7814043
[TBL] [Abstract][Full Text] [Related]
17. 2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human gastric cancer cells through downregulating JNK-mediated cytoprotective autophagy.
Xu Y; Wang Q; Zhang L; Zheng M
Cancer Chemother Pharmacol; 2018 Mar; 81(3):555-564. PubMed ID: 29383484
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity, radiosensitization, and chemosensitization of tumor cells by 2-deoxy-D-glucose in vitro.
Dwarakanath BS
J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S27-31. PubMed ID: 20009290
[TBL] [Abstract][Full Text] [Related]
19. Effect of 2-deoxy-D-glucose on various malignant cell lines in vitro.
Zhang XD; Deslandes E; Villedieu M; Poulain L; Duval M; Gauduchon P; Schwartz L; Icard P
Anticancer Res; 2006; 26(5A):3561-6. PubMed ID: 17094483
[TBL] [Abstract][Full Text] [Related]
20. Protein N-glycosylation alteration and glycolysis inhibition both contribute to the antiproliferative action of 2-deoxyglucose in breast cancer cells.
Berthe A; Zaffino M; Muller C; Foulquier F; Houdou M; Schulz C; Bost F; De Fay E; Mazerbourg S; Flament S
Breast Cancer Res Treat; 2018 Oct; 171(3):581-591. PubMed ID: 29971627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
